TNFR1 signaling is required for the consolidation of fear extinction memory during the resolution phase of neuroinflammation
This study demonstrates that TNFR1 signaling is essential for consolidating fear extinction memory during the resolution phase of neuroinflammation by facilitating a hippocampal BDNF-mediated compensatory response, as its absence leads to cognitive inflexibility despite the lack of active chronic inflammation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The brain is not a static organ; it is a living landscape that constantly reshapes itself in response to experience, a process known as plasticity. This ability to rewire is essential for learning, but it is also fragile. When the body fights an infection, the immune system releases chemical signals called cytokines to coordinate the defense. These same signals can cross into the brain, triggering a state of neuroinflammation. While this response is vital for survival, it often comes at a cognitive cost, causing temporary fog, memory lapses, or difficulty focusing. Scientists have long understood that the acute phase of this inflammation, when the body is actively fighting a threat, disrupts thinking. However, a quieter mystery remains: what happens to the brain's ability to learn and unlearn after the initial fever has broken and the immune system has seemingly calmed down? Does the brain simply return to normal, or does the aftermath of the immune battle leave a hidden scar on how we process fear and safety?
A team of researchers at the University of São Paulo set out to explore this specific window of time, the resolution phase, where the immune system is winding down but the brain is still recovering. They focused on a specific protein receptor called TNFR1, which acts as a switch on the surface of brain cells to receive signals from a key immune messenger known as tumor necrosis factor. While this receptor is famous for driving the initial, aggressive inflammatory response, its role in the later stages of recovery was unclear. To investigate, the researchers used a group of male mice, some of which were genetically bred to lack this receptor entirely. They exposed these animals to a controlled immune challenge by injecting them with a substance that mimics a bacterial infection, causing a temporary state of sickness that lasted for three days. Once the mice had recovered their weight and normal behavior, the scientists began testing their minds, specifically looking at how they learned to forget a fear they had been taught.
The experiment began by teaching the mice to associate a specific room with a mild, harmless electric shock. In this context, the mice learned to freeze in fear whenever they were placed in that room again. The researchers then tested whether the mice could learn that the fear was no longer necessary. This process, called fear extinction, involves learning that a previously scary situation is now safe. The scientists observed that while the initial immune challenge made it harder for all the mice to learn this new safety lesson during the training session, a critical difference emerged the next day. The mice that possessed the TNFR1 receptor were able to solidify this new memory of safety. They remembered that the room was safe and did not freeze when tested again. In stark contrast, the mice missing the TNFR1 receptor failed to hold onto this lesson. Despite going through the same training, they forgot the safety signal and continued to act as if they were still in danger.
This failure to remember the new lesson was not due to general confusion or anxiety. The researchers checked the mice's ability to recognize new objects and their general anxiety levels, finding no differences between the groups. The problem was specific to the ability to consolidate, or lock in, a memory of unlearning fear. To understand why this happened, the team looked inside the brains of the mice, focusing on three key regions: the prefrontal cortex, the amygdala, and the hippocampus. They found that the brain was not in a state of active, raging inflammation. There was no widespread swelling of support cells, and the levels of inflammatory chemicals had largely returned to baseline or even dropped slightly below normal. The brain was not fighting a battle; it was in a state of quiet recovery.
However, a crucial chemical signal was missing in the mice without the receptor. In the healthy mice that had recovered from the immune challenge, the hippocampus—a region vital for memory—showed a significant rise in a protein called BDNF, which acts as a fertilizer for brain cells, helping them grow and strengthen new connections. This rise in BDNF appeared to be the brain's way of repairing itself and supporting the new memory of safety. In the mice lacking the TNFR1 receptor, this compensatory rise never happened. Even though these mice had plenty of the receptors needed to receive the BDNF signal, the signal itself was absent. Without this neurotrophic support, the brain could not stabilize the new learning, leaving the fear memory intact and the new safety memory fragile.
The findings suggest that the TNFR1 receptor plays a dual role in the brain's life cycle. During the height of an infection, it helps drive the immune response. But once the threat has passed, the same receptor is essential for triggering the brain's repair mechanisms. It acts as a bridge between the immune system and the brain's ability to adapt, ensuring that the brain can mount a necessary chemical response to support memory formation after a stressor. The study indicates that the cognitive inflexibility observed in these mice was not caused by lingering inflammation, but rather by a failure to initiate the recovery process. The brain was ready to learn, but without the specific signal provided by the TNFR1 receptor, it could not build the neural pathways required to remember that the danger had passed. This highlights a distinct and vital window in the recovery process where the brain's ability to heal and adapt depends on a precise molecular conversation between the immune system and the memory centers.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.